Cargando…
Lysophosphatidic acid receptor 1 (LPA(1)) plays critical roles in microglial activation and brain damage after transient focal cerebral ischemia
BACKGROUND: Lysophosphatidic acid receptor 1 (LPA(1)) is in the spotlight because its synthetic antagonist has been under clinical trials for lung fibrosis and psoriasis. Targeting LPA(1) might also be a therapeutic strategy for cerebral ischemia because LPA(1) triggers microglial activation, a core...
Autores principales: | Gaire, Bhakta Prasad, Sapkota, Arjun, Song, Mi-Ryoung, Choi, Ji Woong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701099/ https://www.ncbi.nlm.nih.gov/pubmed/31429777 http://dx.doi.org/10.1186/s12974-019-1555-8 |
Ejemplares similares
-
NLRP3 Inflammasome Activation Is Involved in LPA(1)-Mediated Brain Injury after Transient Focal Cerebral Ischemia
por: Lee, Chi-Ho, et al.
Publicado: (2020) -
Sphingosine 1-phosphate receptor subtype 3 (S1P(3)) contributes to brain injury after transient focal cerebral ischemia via modulating microglial activation and their M1 polarization
por: Gaire, Bhakta Prasad, et al.
Publicado: (2018) -
Eupatilin exerts neuroprotective effects in mice with transient focal cerebral ischemia by reducing microglial activation
por: Sapkota, Arjun, et al.
Publicado: (2017) -
S1P(2) contributes to microglial activation and M1 polarization following cerebral ischemia through ERK1/2 and JNK
por: Sapkota, Arjun, et al.
Publicado: (2019) -
BMS-986020, a Specific LPA(1) Antagonist, Provides Neuroprotection against Ischemic Stroke in Mice
por: Gaire, Bhakta Prasad, et al.
Publicado: (2020)